Saturday 17 October 2026 Export RHEP’s income statement to Excel — free account

Adcare Health Systems Inc

Adcare Health Systems Inc’s revenue for fiscal 2025 (year ended December 2025) was $53.2 million, up 189.9% from fiscal 2024. In the quarter to June 2026, revenue grew 143.0%, EPS grew 70.6%, free cash flow grew 224.5% and total debt fell 13.0%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

1.05 0.01 +0.96%

Follow RHEP

Alert me

Market cap: $5.2M
P/E: 0.6×
Fwd P/E: −0.4×
Dividend yield: —
F-score: 5/9
Altman Z: −0.93
Beneish M: −0.24
Dividend safety: n/a

Overview Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total buys 0.09

Total sells 0.01

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	2	—	—	—	1	2	—	—	—	—	—
Sell	—	—	—	—	—	—	—	1	—	—	—	—

Insider Ownership 59.52%

Capital & Financial Ratios $m

Market Cap 5.21

Revenue 81.52

Net Income 4.07

Free Cash Flow 6.06

Net Debt 38.78

Current Ratio 0.65

Debt/Equity 14.29

P/E ratio 0.64

Fwd P/E (0.37)

P/S ratio 0.05

P/B ratio 0.00

Past 5Y EPS Growth —

This Y EPS Growth —

Next Y EPS Growth —

Next Y revenue growth 16.15%

Next 5Y EPS Growth —

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/S against its own 10 years 1.95%

10-year low 10-year high

EV/Sales against its own 10 years 1.95%

10-year low 10-year high

EV/FCF against its own 10 years 13.63%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2020	Powerpack
2019	Powerpack
2018	Powerpack
2017	Powerpack

special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	4	2	5	4
Receivables	1	3	8	10
Inventory	—	—	1	2
Other	11	10	—	—
	18	7	16	18

	2023	2024	2025	Q'26
Payables	2	4	7	7
ST’ Debt	—	10	8	8
Other	—	1	1	2
	7	20	24	27

Compound Annual Growth %

	10y	5y	3y
Sales	11.19%	24.77%	13.95%
Cash Flow	0.00%	0.00%	0.00%
Earnings	0.00%	0.00%	0.00%
Book Value	(36.13%)	(49.94%)	(54.54%)

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	21	24	—	—	—
’25	7	10	15	21	53
’24	4	4	4	6	18
’23	4	5	4	5	17
’22	7	8	11	10	36
’21	7	6	7	6	27
’20	5	5	5	4	18

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(1)	1	—	—	—
’25	0	1	(2)	(1)	(2)
’24	1	1	0	1	2
’23	3	0	1	0	4
’22	(2)	(1)	1	(1)	(4)
’21	2	0	2	1	5
’20	0	0	1	0	1

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(1)	1	—	—	—
’25	0	0	(2)	9	7
’24	1	0	0	1	1
’23	3	0	0	0	3
’22	(2)	(1)	1	(2)	(4)
’21	2	0	2	1	5
’20	0	0	1	0	1

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	(0.29)	(0.20)	—	—	—
’25	(0.94)	(0.68)	1.17	0.95	1.09
’24	(0.52)	(0.38)	(0.52)	(0.31)	(1.73)
’23	(2.28)	(0.36)	(0.52)	(0.13)	(2.07)
’22	(2.89)	(2.02)	(1.48)	(2.54)	(8.93)
’21	(1.32)	(1.62)	(1.27)	(1.66)	(5.87)
’20	(1.34)	(1.09)	(1.38)	(1.93)	(5.74)

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	16.61	1.92	0.72	1.01	0.75	2.80	2.04	1.35	1.13	0.13	Analyst estimates 2026–2028 Powerpack
	High	32.40	20.88	10.56	5.30	15.77	27.72	7.00	4.52	3.08	6.80
People
People	Employees	19	16	16	17	16	15	10	107	256	731
	Revenue/emp, $m	1.45	1.57	1.38	1.18	1.10	1.78	3.59	0.16	0.07	0.07
Income, $m
Income, $m	Revenue	28	25	22	20	18	27	36	17	18	53
	Gross margin, %	100.00	97.48	97.11	96.72	96.16	62.85	41.34	50.05	48.50	28.96
	EBT	6	1	(12)	5	(1)	(1)	(7)	(4)	(3)	3
	EBT margin, %	21.02	2.01	(54.46)	24.21	(3.44)	(4.43)	(19.11)	(22.65)	(17.55)	6.34
	Net income	(7)	(1)	(12)	6	(1)	(1)	(7)	(4)	(3)	3
	Depreciation	6	5	5	4	3	3	2	2	2	2
Per share, $
Per share, $	Revenue	16.66	15.21	13.15	11.93	10.41	15.39	20.23	9.14	9.87	18.95
	Earnings	(8.88)	(5.16)	(11.86)	(2.07)	(5.74)	(5.87)	(8.93)	(2.07)	(1.73)	1.09
	Cash flow	(2.06)	3.11	0.80	1.42	0.77	2.82	(2.02)	1.98	1.05	(0.81)
	Capex	10.18	(1.34)	(0.20)	1.56	(0.27)	(0.07)	(0.16)	(0.51)	(0.29)	3.25
	Free cash flow	8.12	1.77	0.60	2.98	0.50	2.75	(2.18)	1.47	0.76	2.45
	Book value	(22.90)	10.81	3.67	6.96	6.58	6.00	2.09	0.10	(1.57)	0.12
	Shares, m	2	2	2	2	2	2	2	2	2	3
Valuation, ×
Valuation, ×	P/E	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.56
	P/S	1.12	0.15	0.12	0.12	0.34	0.29	0.15	0.23	0.16	0.07
	P/B	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	EV/Sales	3.31	2.69	3.58	2.47	3.50	2.22	1.56	2.52	2.74	0.79
	EV/FCF	6.78	23.10	78.13	9.89	72.81	12.39	(14.48)	15.72	35.50	6.13
Cash, $m
Cash, $m	Operating cash flow	(3)	5	1	2	1	5	(4)	4	2	(2)
	Capex	17	(2)	0	3	0	0	0	(1)	(1)	9
	Free cash flow	13	3	1	5	1	5	(4)	3	1	7
Balance, $m
Balance, $m	Working capital	(5)	(15)	1	3	5	4	0	11	(14)	(8)
	Total debt	76	66	108	55	63	61	55	43	50	43
	Net debt	60	64	101	47	55	51	51	39	47	39
	Shareholders’ equity	(38)	18	6	12	11	10	4	0	(3)	0
Returns, %
Returns, %	ROA	(10.25)	(7.61)	(19.20)	(3.26)	(8.73)	(9.53)	(18.21)	60.43	(5.25)	4.75
	ROIC	12.63	3.94	(0.46)	5.78	2.15	2.57	(7.84)	(1.32)	0.23	2.68
	ROE	47.90	20.85	39.43	6.54	18.99	19.70	28.65	(101.89)	15.78	(16.73)

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
PAIYY Aesthetic Medical International Hldngs Group Ltd Sponsored ADR	$15.9M	— (loss-making)	8.3×	+25,427.42% (above 0%: growing)	n/m	−206.36% (below 0%: shrinking)	42.70%	(1.24%)	Compare
CCM Concord Medical Services Holdings Limited	$10.5M	— (loss-making)	— (loss-making)	+37.65% (above 0%: growing)	n/m	−281.45% (below 0%: shrinking)	(13.15%)	0.00%	Compare
AMS American Shared Hospital Services	$8.4M	— (loss-making)	1.8×	+19.22% (above 0%: growing)	n/m	+195.82% (above 0%: growing)	17.00%	(7.22%)	Compare
CANOQ Cano Health, Inc.	$6.6M	— (loss-making)	—	−21.05% (below 0%: shrinking)	n/m	−43.68% (below 0%: shrinking)	100.00%	(16.23%)	Compare
MODVQ ModivCare Inc.	$6.2M	— (loss-making)	— (loss-making)	−3.18% (below 0%: shrinking)	n/m	−3,767.70% (below 0%: shrinking)	14.06%	(1.78%)	Compare
BMGL Basel Medical Group Ltd	$6.2M	—	—	—	—	—	—	—	Compare
RHEP Adcare Health Systems Inc	$5.2M	0.6×	— (loss-making)	+143.03% (above 0%: growing)	n/m	+224.45% (above 0%: growing)	31.50%	(0.88%)
NIVF NewGenIvf Group Limited	$2.3M	—	—	—	—	—	—	—	Compare
SYRA Syra Health Corp.	$1.1M	84.0×	—	+23.03% (above 0%: growing)	n/m	−892.68% (below 0%: shrinking)	44.53%	10.51%	Compare
Median of peers	$6.4M	—	—	+21.13%	—	−243.90%	29.85%	(1.51%)

All 55 Medical Care Facilities stocks →

Adcare Health Systems Inc (RHEP) key facts

Strength: Adcare Health Systems Inc’s revenue for fiscal 2025 (year ended December 2025) was $53.2 million, up 189.9% from fiscal 2024.
Adcare Health Systems Inc (RHEP) is a Medical Care Facilities company in the Healthcare sector.
As of October 16, 2026, RHEP traded at $1.05, a market capitalization of $5.2 million.
Return on equity was −16.7% and debt-to-equity 14.29.
Its Piotroski F-score is 5 out of 9 and its Altman Z-score is −0.93 (distress zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.